^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Squamous Cell Carcinoma of Head and Neck |
| Drug: | methotrexate (THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
A summary of management strategies for recurrent and/or metastatic SCCHN...Pretreated with platinum based ChT within the last 6 months and immunotherapy naïve...Option...Taxane or methotrexate or cetuximab and/or BSC if contraindication to immunotherapy...
